Oxygen Development LLC: due-diligence report
Public-record summary and buyer worksheet. Records can be incomplete; a listing is not product approval, an audit result or a guarantee of suitability. This report updates as source records change. Print a dated copy to retain the version you reviewed.
Share this report: https://certifiedmanufacturers.com/manufacturers/oxygen-development/due-diligence
Profile last verified: Nov 19, 2026. Report printed / reviewed on: ____________________
Certifications and licences
NSF/ANSI 455-2 GMP for Dietary Supplements
Issuer: NSF. Registry status: active. Checked: Nov 19, 2026.
Reference: Not recorded. Expiry: Not recorded.
Scope: Not recorded here; confirm with the registry and manufacturer.
Registry source: https://info.nsf.org/Certified/455GMP/Listings.asp?Facilities
Oxygen Development LLC, 1441 W Newport Center Drive, Deerfield Beach, FL, 33442, US — manufacturing; source: NSF/ANSI 455-2; checked Nov 19, 2026.
Oxygen Development, LLC, 1525 S Congress Avenue, Palm Springs, FL, 33406, US — manufacturing; source: NSF/ANSI 455-2; checked Nov 19, 2026.
FDA inspection history
Dataset date: Oct 28, 2026. Facility records are matched by company and location; confirm that the site is the one in your quote. FDA inspection source.
May 19, 2026 — NAI: No action indicated
Oxygen Development, L.L.C., Palm Springs, Florida, United States. FEI: 3009461317; inspection: 1295654.
Food Composition, Standards, Labeling and Econ, Foodborne Biological Hazards
Jan 19, 2018 — NAI: No action indicated
Oxygen Development, L.L.C., Palm Springs, Florida, United States. FEI: 3009461317; inspection: 1042460.
Colors and Cosmetics Technology
Nov 22, 2013 — NAI: No action indicated
Oxygen Development, L.L.C., Palm Springs, Florida, United States. FEI: 3009461317; inspection: 857278.
Colors and Cosmetics Technology
21 CFR 211.22(d): Procedures not in writing, fully followed
21 CFR 211.100(a): Absence of Written Procedures
21 CFR 211.170(b): Annual visual exams of drug products
Mar 29, 2013 — VAI: Voluntary action indicated
Oxygen Development, L.L.C., Palm Springs, Florida, United States. FEI: 3009461317; inspection: 824681.
Colors and Cosmetics Technology
21 CFR 211.22(d): Procedures not in writing, fully followed
21 CFR 211.80(d): Disposition recorded by lot identification
21 CFR 211.100(b): SOPs not followed / documented
21 CFR 211.103: Actual vs. theoretical yields not determined
21 CFR 211.110(a): Control procedures fail to include the following
21 CFR 211.113(a): Procedures for non-sterile drug products
21 CFR 211.125(c): Label reconciliation discrepancies evaluation/investigation
21 CFR 211.165(f): Failing drug products not rejected
21 CFR 211.166(a)(4): Testing in same container - closure system
21 CFR 211.170(b): Annual visual exams of drug products
21 CFR 211.186(a): Signature and checking of records -- 2 persons
21 CFR 211.188: Prepared for each batch, include complete information
21 CFR 211.192: Quality control unit review of records
May 11, 2012 — VAI: Voluntary action indicated
Oxygen Development, L.L.C., Palm Springs, Florida, United States. FEI: 3009461317; inspection: 775347.
Colors and Cosmetics Technology
May 29, 2009 — NAI: No action indicated
Oxygen Development, L.L.C., Palm Springs, Florida, United States. FEI: 3009461317; inspection: 584937.
Colors and Cosmetics Technology
21 CFR 211.165(a): Testing and release for distribution
21 CFR 211.180(e)(1): Review of representative number of batches
21 CFR 211.188: Prepared for each batch, include complete information
21 CFR 211.192: Quality control unit review of records
FDA recalls
Dataset date: Nov 19, 2026. Recall matches use company names and may concern a different product or facility.
No matched recall events in the imported dataset. This is not proof of a recall-free history.
Company website claims — not registry verified
Last website check: Oct 16, 2026.
“Oxygen offers both standard and customized formulations driven by:”
Source page language: Italian (declared by website)
Last seen Oct 16, 2026. https://oxygendevelopment.com/know-how/
“ranging from bulk manufacturing to full turnkey solutions”
Source page language: Italian (declared by website)
Last seen Oct 16, 2026. https://oxygendevelopment.com/cosmetics/
Evidence to request from the manufacturer
Public records cannot answer these questions. Mark each item after reviewing the evidence. Blank means not assessed, not a failed audit. Notes entered here are not saved or included in a shared URL.
Request role-specific training records and the named quality contact.
21 CFR 111.12Request a site walkthrough, sanitation controls and equipment maintenance records (also §111.25).
21 CFR 111.20Request written identity, purity, strength, composition and contaminant specifications for your product.
21 CFR 111.70Ask how each dietary ingredient is identified and how suppliers and certificates of analysis are qualified.
21 CFR 111.75Request quality control procedures, release authority and handling of deviations and rejected batches.
21 CFR 111.105Request the approved product-specific master manufacturing record and change-control process.
21 CFR 111.205Review a completed batch record with traceability to components, processing and release.
21 CFR 111.255Request scientifically valid test methods, sampling plans and laboratory controls for your specifications.
21 CFR 111.315Request procedures that prevent label mix-ups and control packaging and label reconciliation.
21 CFR 111.403Ask how storage conditions protect identity, purity, strength and composition during holding and distribution.
21 CFR 111.453Request complaint review and investigation procedures; discuss returned-product controls under §111.503.
21 CFR 111.553Confirm retention and access to records supporting your batches.
21 CFR 111.605